When:
September 26, 2020 @ 9:00 am – 11:00 am
2020-09-26T09:00:00-04:00
2020-09-26T11:00:00-04:00
Where:
Nashville, Tennessee

Oncology Nurses Quality Improvement Series

REGISTER FOR ON QIS MEETING

Saturday, September 26, 2020
9:00 AM – 11:00 AM CT

This virtual program is at 10:00AM Eastern, 9:00AM Central, 8:00AM Mountain, and 7:00AM Pacific.

Access the clinical/provider tool kit, poster portal, and additional resources @ http://oncologynurse-ce.com

 

PROGRAM FEATURES

  • Online Personalized Poster Portal
  • Interactive, case-based learning environment

PRESENTATION TRACKS

Immune Related Adverse Events

Immune Checkpoint Inhibitors: The Oncology Nurse’s Role in the Monitoring and Early Intervention of Immune-related Adverse Events

Arjun V. Balar, MD
Associate Professor of Medicine
Director, Genitourinary Medical Oncology Program
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
New York, NY

HER2-Negative Breast Cancer

Updates for Oncology Nurses—Optimizing the Paradigm Shift Driven by CKD 4/6 Inhibitors in Metastatic HR-Positive, HER2-Negative Breast Cancer

Sramila Aithal, MD
Director and Lead, Breast Center of Advanced Oncology
Medical Oncologist and Hematologist
Cancer Treatment Centers of America
Philadelphia, PA

TARGET AUDIENCE

This initiative is designed to meet the educational needs of oncology nurses involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy, and oncology nurses, medical oncologists, pharmacists, and other healthcare providers involved in the treatment of patients with hormone receptor-positive, HER2-negative metastatic breast cancer.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 2.0 AMA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of patients with cancer who are treated or eligible for treatment with immunotherapy or patients with hormone receptor-positive HER2-negative metastatic breast cancer.

Credits:

2.0 ANCC Contact Hours

CNE ACCREDITATION STATEMENT:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.0 contact hours of continuing nursing education of RNs and APNs.

ONCC RECERTIFICATION POINTS

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

 

 

REGISTER FOR ON QIS MEETING